Spiriva
This inhaler is indicated to relieve chronic obstructive pulmonary disease and is developed to support improved respiratory function.
Strengths: 9mcg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Tiova Rotacap
- Therapeutic class
Anticholinergic
- Pharmacological class
Muscarinic Antagonist
- Known off-label uses
asthma
- Contraindications
hypersensitivity to tiotropium or ipratropium
- Minor side effects
dry mouth; constipation; dizziness
- Moderate side effects
pharyngitis; dysphonia; urinary retention
- Dosage forms
Inhalation powder, hard capsule
- Administration route
Inhalation use
- Prescription status
POM
- Manufacturer
Boehringer Ingelheim
- Onset Time
30 minutes
- Duration
24 hours
- Storage instructions
Store at room temperature in a dry place.
- Drug interactions
ipratropium
- Age restrictions
Adults.
- Pregnancy and breastfeeding
Pregnancy: No data, use with caution. Breastfeeding: Consult physician.
Precautions and warnings
avoid getting powder in eyes; use with caution in narrow-angle glaucoma; inform doctor of urinary retention
Serious side effects
paradoxical bronchospasm — requires immediate medical attention; glaucoma exacerbation — requires immediate medical attention
Patient summary
This inhaler is indicated to relieve chronic obstructive pulmonary disease and is developed to support improved respiratory function.
Mechanism of action
Tiotropium is a long-acting muscarinic antagonist (LAMA). It inhibits the M3-receptors in the smooth muscle of the airway, preventing contraction and resulting in bronchodilation, which facilitates easier breathing over an extended period.
Spiriva
This inhaler is indicated to relieve chronic obstructive pulmonary disease and is developed to support improved respiratory function.
Editorial Notes
- Active ingredient(s): Tiotropium
- Listed indication(s): Chronic Obstructive Pulmonary Disease
Available option
- 3 inhalers - 9 mcg436-9-mcg-12182